Figure 2: Kaplan-Meier survival curves of MTRR66A > G dominant genotypes for overall survival of GC patients received adjuvant chemotherapy. | Scientific Reports

Figure 2: Kaplan-Meier survival curves of MTRR66A > G dominant genotypes for overall survival of GC patients received adjuvant chemotherapy.

From: The effects of genomic polymorphisms in one-carbon metabolism pathways on survival of gastric cancer patients received fluorouracil-based adjuvant therapy

Figure 2

(A) Overall survival of MTRR66A > G dominant genotypes in stage II chemotherapy patients. (B) Overall survival of MTRR66A > G dominant genotypes in stage III chemotherapy patients.

Back to article page